Evidence map›Paper›PMID 35993700›Full record

ArticlemSphere2022

Clostridioides difficile Modifies its Aromatic Compound Metabolism in Response to Amidochelocardin-Induced Membrane Stress.

Madita Brauer, Sven-Kevin Hotop, Martina Wurster, Jennifer Herrmann, Marcus Miethke, Rabea Schlüter, Silvia Dittmann, Daniela Zühlke, Mark Brönstrup, Michael Lalk and 4 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. The Thioredoxin Fold Protein (TFP2) from Extreme AcidophilicInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Madita BrauerInstitute of Microbiology, University of Greifswaldgrid.5603.0, Greifswald, Germany.ORCID 0000-0001-9709-9155
Sven-Kevin HotopHelmholtz Centre for Infection Researchgrid.7490.a, Department of Chemical Biology, Braunschweig, Germany.
Martina WursterInstitute of Biochemistry, University of Greifswaldgrid.5603.0, Greifswald, Germany.
Jennifer HerrmannHelmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Researchgrid.7490.a (HZI) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.
Marcus MiethkeHelmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Researchgrid.7490.a (HZI) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.
Rabea SchlüterImaging Center of the Department of Biology, University of Greifswaldgrid.5603.0, Greifswald, Germany.
Silvia DittmannInstitute of Microbiology, University of Greifswaldgrid.5603.0, Greifswald, Germany.
Daniela ZühlkeInstitute of Microbiology, University of Greifswaldgrid.5603.0, Greifswald, Germany.
Mark BrönstrupHelmholtz Centre for Infection Researchgrid.7490.a, Department of Chemical Biology, Braunschweig, Germany.ORCID 0000-0002-8971-7045
Michael LalkInstitute of Biochemistry, University of Greifswaldgrid.5603.0, Greifswald, Germany.
Rolf MüllerHelmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Researchgrid.7490.a (HZI) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.
Susanne SieversInstitute of Microbiology, University of Greifswaldgrid.5603.0, Greifswald, Germany.ORCID 0000-0002-5457-2552
Jörg BernhardtInstitute of Microbiology, University of Greifswaldgrid.5603.0, Greifswald, Germany.
Katharina RiedelInstitute of Microbiology, University of Greifswaldgrid.5603.0, Greifswald, Germany.ORCID 0000-0002-4629-3019
Universität Greifswald · DEGerman Center for Infection Research · DEHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amidochelocardin is a broad-spectrum antibiotic with activity against many Gram-positive and Gram-negative bacteria. According to recent data, the antibiotic effect of this atypical tetracycline is directed against the cytoplasmic membrane, which is associated with the dissipation of the membrane potential. Here, we investigated the effect of amidochelocardin on the proteome of Clostridioides difficile to gain insight into the membrane stress physiology of this important anaerobic pathogen. For the first time, the membrane-directed action of amidochelocardin was confirmed in an anaerobic pathogen. More importantly, our results revealed that aromatic compounds potentially play an important role in C. difficile upon dissipation of its membrane potential. More precisely, a simultaneously increased production of enzymes required for the synthesis of chorismate and two putative phenazine biosynthesis proteins point to the production of a hitherto unknown compound in response to membrane depolarization. Finally, increased levels of the ClnAB efflux system and its transcriptional regulator ClnR were found, which were previously found in response to cationic antimicrobial peptides like LL-37. Therefore, our data provide a starting point for a more detailed understanding of C. difficile

Indexed as

Clostridioides difficileAnti-Bacterial AgentsClostridioidesGram-Negative BacteriaGram-Positive BacteriaPhenazinesProteomeTetracyclinesAnti-Bacterial AgentsPhenazinesProteomeTetracyclinesamidochelocardinaromatic amino acidschelocardinClnRABClostridioides difficilemembrane potentialphenazineproteomicsproton motive force

Identifiers

PMID35993700
PMCPMC9599328
OpenAlexW4292607997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.